| Primary |
| Product Used For Unknown Indication |
33.9% |
| Drug Use For Unknown Indication |
30.0% |
| Hypokalaemia |
7.0% |
| Hypertension |
5.3% |
| Blood Potassium Decreased |
4.1% |
| Parenteral Nutrition |
2.9% |
| Torsade De Pointes |
2.9% |
| Haematoma Infection |
2.4% |
| Mineral Supplementation |
1.7% |
| Blood Potassium |
1.2% |
| Pain |
1.2% |
| Cardiac Disorder |
1.0% |
| Diuretic Therapy |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Prophylaxis Of Nausea And Vomiting |
1.0% |
| Cardiac Failure |
0.7% |
| Cardiac Failure Congestive |
0.7% |
| Hypothyroidism |
0.7% |
| Vitamin Supplementation |
0.7% |
| Allergic Granulomatous Angiitis |
0.5% |
|
| Hyperkalaemia |
14.1% |
| Medication Error |
10.9% |
| Completed Suicide |
10.2% |
| Death |
10.2% |
| Medication Residue |
8.6% |
| Wrong Drug Administered |
6.3% |
| Product Packaging Issue |
3.9% |
| Tachycardia |
3.9% |
| Pharmaceutical Product Complaint |
3.1% |
| Product Substitution Issue |
3.1% |
| Renal Failure |
3.1% |
| Renal Failure Acute |
3.1% |
| Respiratory Arrest |
3.1% |
| Ventricular Tachycardia |
3.1% |
| Circumstance Or Information Capable Of Leading To Medication Error |
2.3% |
| Pharyngeal Oedema |
2.3% |
| Suicide Attempt |
2.3% |
| Vomiting |
2.3% |
| Wrong Technique In Drug Usage Process |
2.3% |
| Abdominal Pain Upper |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
33.5% |
| Drug Use For Unknown Indication |
21.1% |
| Hypertension |
9.1% |
| Pain |
3.9% |
| Electrolyte Substitution Therapy |
3.0% |
| Hypokalaemia |
2.8% |
| Cardiac Failure |
2.8% |
| Sedation |
2.6% |
| Thrombosis Prophylaxis |
2.5% |
| Supplementation Therapy |
2.5% |
| Diabetes Mellitus |
2.2% |
| Sleep Disorder |
2.1% |
| Parenteral Nutrition |
2.1% |
| Pneumonia |
1.7% |
| Polyuria |
1.5% |
| Mineral Supplementation |
1.5% |
| Prophylaxis |
1.4% |
| Depression |
1.3% |
| Fluid Replacement |
1.2% |
| Diarrhoea |
1.2% |
|
| Completed Suicide |
17.5% |
| Toxic Epidermal Necrolysis |
16.4% |
| Hyperkalaemia |
8.1% |
| Renal Failure Acute |
5.9% |
| Toxicity To Various Agents |
5.5% |
| Death |
4.3% |
| Respiratory Arrest |
4.3% |
| Medication Error |
4.0% |
| Vomiting |
4.0% |
| Swollen Tongue |
3.6% |
| Urinary Tract Infection |
3.6% |
| Weight Decreased |
3.6% |
| Thrombocytopenia |
2.8% |
| Cardio-respiratory Arrest |
2.4% |
| Overdose |
2.4% |
| Renal Failure |
2.4% |
| Sepsis |
2.4% |
| Stevens-johnson Syndrome |
2.4% |
| Visual Impairment |
2.4% |
| Weight Increased |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.5% |
| Drug Use For Unknown Indication |
28.3% |
| Hypertension |
6.9% |
| Prophylaxis |
4.5% |
| Pain |
4.4% |
| Multiple Myeloma |
2.3% |
| Rheumatoid Arthritis |
2.2% |
| Diabetes Mellitus |
2.1% |
| Atrial Fibrillation |
2.1% |
| Nausea |
1.8% |
| Depression |
1.8% |
| Pulmonary Arterial Hypertension |
1.7% |
| Constipation |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Osteoporosis |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Anxiety |
1.2% |
| Cardiac Disorder |
1.2% |
| Insomnia |
1.2% |
| Mineral Supplementation |
1.2% |
|
| Vomiting |
15.2% |
| Weight Decreased |
9.4% |
| Weight Increased |
7.6% |
| Death |
6.2% |
| Pneumonia |
6.1% |
| Urinary Tract Infection |
5.4% |
| Thrombocytopenia |
4.6% |
| Nausea |
4.5% |
| Renal Failure Acute |
4.2% |
| Sepsis |
4.1% |
| Dyspnoea |
3.8% |
| Pain |
3.6% |
| Pyrexia |
3.5% |
| Renal Failure |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Oedema Peripheral |
3.2% |
| Syncope |
3.0% |
| Pulmonary Embolism |
2.9% |
| Myocardial Infarction |
2.9% |
| Tremor |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
25.3% |
| Hepatosplenic Candidiasis |
15.2% |
| Drug Use For Unknown Indication |
11.1% |
| Hypertension |
6.1% |
| Ill-defined Disorder |
6.1% |
| Fibromyalgia |
4.0% |
| Atrial Fibrillation |
3.0% |
| Blood Pressure Abnormal |
3.0% |
| Cardiac Disorder |
3.0% |
| Oedema |
3.0% |
| Arthritis |
2.0% |
| Basedow's Disease |
2.0% |
| Blood Potassium |
2.0% |
| Dementia |
2.0% |
| Depression |
2.0% |
| Fluid Retention |
2.0% |
| Nervousness |
2.0% |
| Prophylaxis |
2.0% |
| Prostatic Disorder |
2.0% |
| Stress Urinary Incontinence |
2.0% |
|
| Drug Interaction |
15.2% |
| Sinoatrial Block |
12.1% |
| Arrhythmia |
6.1% |
| Asthenia |
6.1% |
| Atrioventricular Block Second Degree |
6.1% |
| Hypoglycaemia |
6.1% |
| Renal Failure Acute |
6.1% |
| Sinus Bradycardia |
6.1% |
| Dyspnoea |
3.0% |
| Grand Mal Convulsion |
3.0% |
| Haemorrhoidal Haemorrhage |
3.0% |
| Hyperkalaemia |
3.0% |
| Hypotension |
3.0% |
| Memory Impairment |
3.0% |
| Nasal Disorder |
3.0% |
| Nausea |
3.0% |
| Oedema Peripheral |
3.0% |
| Pain |
3.0% |
| Product Substitution Issue |
3.0% |
| Renal Failure |
3.0% |
|
